Livmarli (Maralixibat)

• Baseline liver tests must be obtained and patients must be monitored throughout treatment. It is advisable to consider dose reduction or treatment interruption if abnormalities appear in the absence of other causes. For constant or recurrent liver test abnormalities,  treatment can be discontinued. 
• Treatment with Livmarli was not assessed in ALGS patients struggling with cirrhosis. Monitor patients throughout the therapy with livmarli 9.5 mg oral solution for elevations in liver tests and for the occurrence of liver-related toxicity.
• Vomiting, diarrhea, and abdominal pain may occur as the most common side effects in patients treated with Maralixibat. If these side effects occur, consider reducing the dose or interrupting Maralixibat dosing. For vomiting or diarrhea, monitor patients for dehydration and treat them quickly.
• ALGS patients can have a fat-soluble vitamin deficiency. This medicine may affect the absorption of fat-soluble vitamins. Serum FSV levels should be obtained and patients should be monitored throughout the therapy, together with any probable clinical manifestations.
• In case a fat-soluble vitamin deficiency is diagnosed, supplement it with fat-soluble vitamin. Consider discontinuing Livmarli treatment if fat-soluble vitamins deficiency persists or worsens despite adequate fat-soluble vitamin supplementation.

What documents are required to import LIVMARLI to India?

LIVMARLI (maralixibat) oral solution can be imported by patients or government hospitals in the name of the patients only.

The following documentation is required to import the product:

1. A valid prescription from a qualified doctor.
2. Patient’s diagnostic reports
3. Patient’s ID Proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

1. A valid prescription from the Doctor
2. Import permit if applicable

Is LIVMARLI available in India?

LIVMARLI (maralixibat oral solution) is a prescription drug that legally requires a medical prescription to be dispensed.

Urgent Meds helps import cancer medicines on the named patient supply (NPS). Urgent Meds provides input on:

• Availability of Livmarli in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• Medicine Price.
• Finding genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

LIVMARLI can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

Urgent Meds can facilitate the supply of LIVMARLI (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).

Please contact +1-647-818-4196 or write to us at info@urgentmeds.in for Livmarli price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Urgent Meds is proficient in sourcing LIVMARLI (Cancer Treatment Medicines)  from around the world and has the capability to supply it. We offer global access to the best available treatment for our customers worldwide.

Urgent Meds is committed to dispensing any valid prescription promptly. All prescriptions are dispensed and verified by registered pharmacists and are dispatched only to the patient’s address from New Delhi, India. Your health and well-being are our top priorities.

What is the Generic Name for the trade name drug Livmarli®?

Maralixibat is the Generic Name for the trade name drug Livmarli®.

What is the Manufacturer’s Name of Livmarli®?

Livmarli® is manufactured by Mirum Pharmaceuticals, Inc.

Is Livmarli® approved by the FDA?

Yes, Livmarli® is approved by the FDA. Date of first approval: September 29, 2021.

Where can I get Livmarli® at the best price in India?

To get the best Livmarli price in India, kindly get in touch with Urgent Meds (a WHO GDP & ISO 9001:2008 certified company). For Livmarli®, a valid medical prescription is required from your treating physician.

What is the dosage and form of Livmarli® supplied?

Livmarli® is supplied as an oral solution: 9.5 mg of maralixibat per mL for oral administration.

What are the most common side effects of Livmarli®?

The most common side effects of Livmarli are vomiting, diarrhea, abdominal pain, fat-soluble vitamin deficiency, gastrointestinal bleeding, liver test abnormalities, and bone fractures.

How much does Livmarli® cost in India?

The Livmarli cost in India can vary. In order to procure this IBAT inhibitor authentically, you can call or WhatsApp +1-647-818-4196 or send mail to info@urgentmeds.in.

What are the storage conditions of Livmarli®?

Store Livmarli between 20 and 25°C (68 and 77°F), excursions permitted between 15 and 30°C (59 and 86°F). Discard any left medicine 45 days after the first opening of the bottle.

Is it safe to buy Livmarli® online from India?

Yes, one can buy Livmarli from India at the best price from Urgent Meds if Livmarli has not been approved or is not available in your home country. We can help facilitate the supply of 9.5 mg of Livmarli through legal channels.

For more information, please contact +1-647-818-4196 or email us at info@urgentmeds.in.